Attenuation of the inflammatory changes and lipid anomalies by epigallocatechin-3-gallate in hypercholesterolemic diet fed aged rats

Experimental Gerontology

Volumn 44, Issue 12, 2009, Pages 745-751

  Senthil Kumaran, Vadivel ^a   Arulmathi, Karpagavinayagam ^a   Sundarapandiyan, Rajaguru ^a   Kalaiselvi, Periandavan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Aging; Epigallocatechin gallate; Hypercholesterolemia; Inflammation; Lipids

Indexed keywords

CHOLESTEROL; CHOLIC ACID; ENZYME; EPIGALLOCATECHIN GALLATE; FLAVONOID; GREEN TEA EXTRACT; LIPID;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; HYPERCHOLESTEROLEMIA; INFLAMMATION; JUVENILE ANIMAL; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; WISTAR RAT;

AGING; ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CATECHIN; DIET, ATHEROGENIC; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPIDS; MALE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 70449732159     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.08.010     Document Type: Article

References (42)

1. Abe K., Ijiri M., Suzuki T., Taguchi K., Koyama Y., and Isemura M. Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver. Biomed. Res. 26 (2005) 187-192
2. Augustyniak A., Waszkiewicz E., and Skrzydlewska E. Preventive action of green tea from changes in the liver antioxidant abilities of different aged rats intoxicated with ethanol. Nutrition 21 (2005) 925-932
3. Batetta B., Mulas M.F., Petruzzo P., Putzolu M., Bonatesta R.R., Sanna F., Cappai A., Brotzu G., and Dessì S. Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cell. Mol. Life Sci. 58 (2001) 1113-1120
4. Blake G.J., and Ridker P.M. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1512-1513
5. Bose C., Bhuvaneswaran C., and Udupa K.B. Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK. Mech. Aging Dev. 126 (2005) 740-751
6. Brüünsgaard H., and Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am. 23 (2003) 15-39
7. Bruunsgaard H., Skinhøj P., Pedersen A.N., Schroll M., and Pedersen B.K. Aging, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin. Exp. Immunol. 121 (2000) 255-260
8. Deepa P.R., and Varalakshmi P. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats. Clin. Chim. Acta 355 (2005) 119-130
9. Deepa P.R., and Varalakshmi P. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin. Chim. Acta 339 (2004) 105-115
10. Duncan A.K., Vittone J., Fleming K.C., and Smith H.C. Cardiovascular disease in elderly patients. Mayo Clin. Proc. 71 (1996) 184-196
11. Folch J., Lees H., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-507
12. Folkow B., and Svanborg A. Physiology of cardiovascular aging. Physiol. Rev. 73 (1993) 725-764
13. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
14. Granger D.N. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 6 (1999) 167-178
15. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141 (1998) 1-15
16. Högberg J., Larson R.E., Kristoferson A., and Orrenius S. NADPH-dependent reductase solubilized from microsomes by peroxidation and its activity. Biochem. Biophys. Res. Commun. 56 (1974) 836-842
17. Kuhn D.J., Burns A.C., Kazi A., and Dou Q.P. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor. Biochim. Biophys. Acta 1682 (2004) 1-10
18. LaRosa J.C., Hunninghake D., Bush D., Criqui M.H., Getz G.S., Gotto Jr. A.M., Grundy S.M., Rakita L., Robertson R.M., Weisfeldt M.L., et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 81 (1990) 1721-1733
19. Lempert, H.C., 1969. Determination of plasma protein. In: Varley, H., (Ed.), Practical Clinical Biochemistry, fourth ed. CBS Publishers, New Delhi, India, 1969, p. 233.
20. Meade T.W. Risk associations in the thrombotic disorders. Clin. Haematol. 10 (1981) 391-405
21. Miura Y., Chiba T., Miura S., Tomita I., Umegaki K., Ikeda M., and Tomita T. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J. Nutr. Biochem. 11 (2000) 216-222
22. Miura Y., Chiba T., Tomita I., Koizumi H., Miura S., Umegaki K., Hara Y., Ikeda M., and Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr. 131 (2001) 27-32
23. Mukhtar H., and Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr. 71 (2000) 1698S-1702S discussion 1703S-1704S
24. Murase T., Nagasawa A., Suzuki J., Hase T., and Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 1459-1464
25. Osada K., Takahashi M., Hoshina S., Nakamura M., Nakamura S., and Sugano M. Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 128 (2001) 153-164
26. Parekh A.C., and Jung D.H. Cholesterol determination with ferric chloride-uranium acetate and sulphuric acid-ferrous sulphate reagents. Anal. Chem. 42 (1970) 1423-1427
27. Raederstorff D.G., Schlachter M.F., Elste V., and Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem. 14 (2003) 326-332
28. Rauchhaus M., Koloczek V., Volk H., Kemp M., Niebauer J., Francis D.P., Coats A.J., and Anker S.D. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int. J. Cardiol. 76 (2000) 125-133
29. Rice E.W. Triglycerides ("neutral fats") in serum. In: Mac-Donald R.P. (Ed). Standard Methods of Clinical Chemistry vol. 6 (1970), Academic Press, New York 215-222
30. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997) 973-979
31. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
32. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
33. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., and Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
34. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
35. Sazuka M., Itoi T., Suzuki Y., Odani S., Koide T., and Isemura M. Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Biosci. Biotechnol. Biochem. 60 (1996) 1317-1319
36. Senthil Kumaran V., Arulmathi K., Srividhya R., and Kalaiselvi P. Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp. Gerontol. 43 (2008) 176-183
37. Talwar, G.P., 1983. Non-isotopic immunoassays and their applications. In: Talwar, G.P. (Ed.), Vikas Publishing House Pvt. Ltd., India, pp. 55-62.
38. Tijburg L.B., Wiseman S.A., Meijer G.W., and Weststrate J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135 (1997) 37-47
39. Wilson D.E., and Spiger M.J. A dual precipitation method for quantitative lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med. 82 (1973) 473-483
40. Yang C.S., and Landau J.M. Effects of tea consumption on nutrition and health. J. Nutr. 130 (2000) 2409-2412
41. Yang F., de Villiers W.J., McClain C.J., and Varilek G.W. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128 (1998) 2334-2340
42. Yokozawa T., Nakagawa T., and Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J. Agric. Food Chem. 50 (2002) 3549-3552